Newscast – Page 88 – media

Telemedicine robot enables physician consultations in multiple locations

Using the device, called a Beam, Miramont Family Medicine now sees more patients than ever – enabling physicians to be in more than one of its four locations at the same time.
- Source: HealthIT News
- 545
- April 17, 2018
Company Insights mHealth Telemedicine
Sword Health lands $4.6M for digital physical therapy

Digital physiotherapy company Sword Health has brought in $4.6 million in a seed funding round led by Green Innovation, Vesalius Biocapital III, and other unnamed US and European investors.
- Source: MobiHealthNews
- 840
- April 17, 2018
AI Company Insights digital health
GSK hands rare disease gene therapies over to Orchard

Orchard Therapeutics has snapped up GlaxoSmithKline’s portfolio of approved and investigational rare disease gene therapies. The deal sees GSK become an investor in Orchard, with a 19.9 percent equity stake along with a seat on the firm’s board. The UK drugs giant also stands to receive royalties and commercial milestone payments related to the acquired portfolio.
- Source: pharmatimes
- 665
- April 16, 2018
GSK Market Views rare disease gene therapies
RubrYc Therapeutics Completes $10M Million Series A Financing

RubrYc Therapeutics, Inc., a biotherapeutics discovery business, announced today it has closed a $10 million Series A Preferred Equity financing round led by Third Point Ventures, with participation by Paladin Capital Group and Vital Venture Capital.
- Source: prnewswire
- 929
- April 16, 2018
antibody biotherapeutics Series
A healthcare startup to improve dose management for injectable drugs raises $6.6M

The FDA confirmed in a March 16, 2012 communication released to Bloomberg News that the vaginally placed pelvic mesh product known as the Prolift, sold by Johnson & Johnson subsidiary Ethicon, Inc. since March, 2005, was initially marketed without any clearance or approval from the FDA.
- Source: Med City News
- 515
- April 16, 2018
Company Insights digital health
Oxygen device maker Inogen discloses customer data breach

Oxygen supply device maker Inogen Inc said on Friday it was notifying 30,000 existing and former customers following a data breach that led to improper access of personal details of some rental clients.
- Source: Reuters
- 495
- April 16, 2018
Company Insights cybersecurity EHR
50 percent of EHR-using docs unsatisfied with patient data access

A recent survey of 300 primary care physicians who use EHRs found that half of the respondents wanted better access to patient data.
- Source: MobiHealthNews
- 621
- April 16, 2018
digital health EHR Researches
Bristol-Myers Squibb and Harvard Announce New Fibrosis Research Collaboration

Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute today announce a research collaboration to discover and develop potential new therapies for fibrotic diseases, including fibrosis of the liver and heart. The Harvard Fibrosis Network brings together researchers across the schools and affiliated hospitals of Harvard University.
- Source: news.bms
- 598
- April 13, 2018
Bristol-Myers Squibb fibrotic diseases
Cellectis Snags $164 Million in IPO to Advance CAR-T Programs

Today the company has found some sure financial footing that will support its efforts through the remainder of the year. The company secured $163.7 million in an initial public offering. The funding will be used to continue the development of Cellectis’ off-the-shelf CAR-T products and drive them toward regulatory approval.
- Source: biospace
- 673
- April 13, 2018
CAR-T therapies Series
Security Fears Outweigh Benefits in Mobile Device Management Report

A global survey of healthcare executives finds significant satisfaction in mobile device programs, but a lack of faith in mHealth security.
- Source: mHealthIntelligence
- 488
- April 13, 2018
digital health Market Views mHealth

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.